Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemo-Radiotherapy for Refractory and Relapsed Hodgkin's Disease
NCT00003631Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 1998
- Primary completion
- Apr 2010
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, carboplatin, etoposide, cyclophosphamide, carmustine in Hodgkin lymphoma (HL), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 1998; status: completed.
02
Drugs
ifosfamidecarboplatinetoposidecyclophosphamidecarmustine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00003631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003631.